Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 371.5 DKK -0.44% Market Closed
Market Cap: 90.8B DKK

Balance Sheet

Balance Sheet Decomposition
Genmab A/S

Current Assets 27.9B
Cash & Short-Term Investments 21.1B
Receivables 6.7B
Other Current Assets 62m
Non-Current Assets 18B
Long-Term Investments 228m
PP&E 1.9B
Intangibles 14.9B
Other Non-Current Assets 960m

Balance Sheet
Genmab A/S

Rotate your device to view
Balance Sheet
Currency: DKK
Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
874
307
1 348
533
3 552
7 260
8 957
9 893
14 867
9 858
Cash Equivalents
874
307
1 348
533
3 552
7 260
8 957
9 893
14 867
9 858
Short-Term Investments
2 619
3 615
4 075
5 573
7 419
8 819
10 381
12 431
13 268
11 243
Total Receivables
175
976
637
1 327
2 990
2 712
3 398
5 894
4 947
6 691
Accounts Receivables
175
976
579
1 327
2 990
2 463
3 367
5 712
4 947
6 590
Other Receivables
0
0
58
0
0
249
31
182
0
101
Inventory
0
0
0
0
0
0
0
0
57
62
Total Current Assets
3 668
4 898
6 059
7 433
13 961
18 791
22 736
28 218
33 139
27 854
PP&E Net
29
32
113
162
414
736
975
1 322
1 641
1 891
PP&E Gross
29
32
113
162
414
736
975
1 322
1 641
1 891
Accumulated Depreciation
129
132
135
151
189
264
368
495
676
837
Intangible Assets
193
182
124
470
470
338
254
146
101
12 343
Goodwill
0
0
0
0
0
0
0
0
0
2 535
Note Receivable
7
1
9
10
11
20
27
48
62
52
Long-Term Investments
0
0
0
0
149
1 081
371
133
134
228
Other Long-Term Assets
6
125
297
386
139
177
264
252
212
908
Other Assets
0
0
0
0
0
0
0
0
0
2 535
Total Assets
3 903
N/A
5 238
+34%
6 603
+26%
8 461
+28%
15 144
+79%
21 143
+40%
24 627
+16%
30 119
+22%
35 289
+17%
45 811
+30%
Liabilities
Accounts Payable
0
0
0
0
0
0
350
245
330
644
Accrued Liabilities
0
0
0
0
0
0
296
481
637
720
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
26
42
62
74
90
92
Other Current Liabilities
414
412
327
443
912
1 211
860
1 023
1 427
3 852
Total Current Liabilities
414
412
327
443
938
1 253
1 568
1 823
2 484
5 308
Long-Term Debt
0
0
0
0
155
277
363
523
680
937
Deferred Income Tax
0
0
0
0
0
0
0
0
0
2 359
Other Liabilities
1
0
4
3
3
492
500
491
515
510
Total Liabilities
416
N/A
412
-1%
331
-20%
447
+35%
1 096
+145%
2 022
+84%
2 431
+20%
2 837
+17%
3 679
+30%
9 114
+148%
Equity
Common Stock
60
60
61
61
65
66
66
66
66
66
Retained Earnings
4 228
3 003
1 855
197
2 130
7 107
10 020
14 809
19 023
23 551
Additional Paid In Capital
7 561
7 770
7 984
8 059
11 755
11 894
12 029
12 309
12 461
12 590
Other Equity
94
0
82
92
98
54
81
98
60
490
Total Equity
3 487
N/A
4 827
+38%
6 272
+30%
8 014
+28%
14 048
+75%
19 121
+36%
22 196
+16%
27 282
+23%
31 610
+16%
36 697
+16%
Total Liabilities & Equity
3 903
N/A
5 238
+34%
6 603
+26%
8 461
+28%
15 144
+79%
21 143
+40%
24 627
+16%
30 119
+22%
35 289
+17%
45 811
+30%
Shares Outstanding
Common Shares Outstanding
60
60
61
61
65
65
65
65
65
64